The retinoblastoma protein and cell cycle control

Bates, 1994, Absence of cyclin D/cdk complexes in cell lacking functional retinoblastoma protein, Oncogene, 9, 1633 Beijersbergen, 1994, ESF-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo, Genes Dev., 8, 2680, 10.1101/gad.8.22.2680 Caldas, 1994, Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma, Nature Genet., 8, 27, 10.1038/ng0994-27 Cao, 1992, Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F, Nature, 355, 176, 10.1038/355176a0 Chellappan, 1991, The E2F transcription factor is a cellular target for the RB protein, Cell, 65, 1053, 10.1016/0092-8674(91)90557-F Clarke, 1992, Requirement for a functional Rb-1 gene in murine development, Nature, 359, 328, 10.1038/359328a0 Cobrinik, 1992, The retinoblastoma protein and the regulation of cell cycling, Trends Biochem. Sci., 17, 312, 10.1016/0968-0004(92)90443-D Cobrinik, 1993, Cell cycle-specific association of E2F with the p130 E1Abinding protein, Genes Dev., 7, 2392, 10.1101/gad.7.12a.2392 DeCaprio, 1989, The product of the retinoblastoma gene has properties of a cell cycle regulatory element, Cell, 58, 1085, 10.1016/0092-8674(89)90507-2 Desai, 1992, Activation of human cyclin-dependent kinases in vitro, Mol. Biol. Cell, 3, 571, 10.1091/mbc.3.5.571 Donehower, 1992, Mice deficient for p53 are developmentally normal but suceptible to spontaneous tumors, Nature, 356, 215, 10.1038/356215a0 Dowdy, 1993, Physical interaction of the retinoblastoma protein with human cyclins, Cell, 73, 499, 10.1016/0092-8674(93)90137-F Dulic, 1994, p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest, Cell, 76, 1013, 10.1016/0092-8674(94)90379-4 Dynlacht, 1994, Differential regulation of E2 F transactivation by cyclin/cdk2 complexes, Genes. Dev., 8, 1772, 10.1101/gad.8.15.1772 Dyson, 1993, Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1, J. Virol., 67, 7641, 10.1128/JVI.67.12.7641-7647.1993 Dyson, 1989, The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product, Science, 243, 934, 10.1126/science.2537532 El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P Ewen, 1993, Functional interactions of the retinoblastoma protein with mammalian D-type cyclins, Cell, 73, 487, 10.1016/0092-8674(93)90136-E Ewen, 1993, TGFO inhibition of Cdk4 synthesis is linked to cell cycle arrest, Cell, 74, 1009, 10.1016/0092-8674(93)90723-4 Fisher, 1994, A novel cyclin associates with MO151CDK7 to form the CDK-activating kinase, Cell, 78, 713, 10.1016/0092-8674(94)90535-5 Ginsburg, 1994, E2F-4, a new E2F transcription factor family member, interacts with p107 and has transforming potential, Genes Dev., 8, 2665, 10.1101/gad.8.22.2665 Guan, 1994, Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function, Genes Dev., 8, 2939, 10.1101/gad.8.24.2939 Hall, 1993, High levels of p53 protein in UV-irradiated normal human skin, Oncogene, 8, 203 Hannon, 1994, p15INK4B is a potential effector of TGFO induced cell cycle arrest, Nature, 371, 257, 10.1038/371257a0 Harper, 1993, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell, 75, 805, 10.1016/0092-8674(93)90499-G Hatakeyama, 1994, Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein, Genes Dev., 8, 1759, 10.1101/gad.8.15.1759 Hayflick, 1965, The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9 He, 1994, CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines, Cancer Res., 54, 5804 Hinds, 1992, Regulation of retinoblastoma protein functions by ectopic expression of human cyclins, Cell, 70, 993, 10.1016/0092-8674(92)90249-C Horowitz, 1990, Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumor cells, 87, 2775 Hussussian, 1994, Germline p16 mutations in familial melanoma, Nature Genet., 8, 15, 10.1038/ng0994-15 Jacks, 1992, Effects of an RB mutation in the mouse, Nature, 359, 295, 10.1038/359295a0 Jen, 1994, Deletion of p15 and p16 genes in brain tumors, Cancer Res., 54, 6353 Jiang, 1992, Amplification and expression of the human cyclin D gene in esophageal cancer, Cancer Res., 52, 2980 Johnson, 1993, Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature, 365, 349, 10.1038/365349a0 Jung, 1994, Virus-encoded cyclin, Mol. Cell. Biol., 14, 7235, 10.1128/MCB.14.11.7235 Kamb, 1994, A cell cycle regulator potentially involved in genesis of many tumor types, Science, 264, 436, 10.1126/science.8153634 Kamb, 1994, Analysis of the pl6 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus, Nature Genet., 8, 23, 10.1038/ng0994-22 Kastan, 1991, Participation of p53 protein in the cellular response to DNA damage, Cancer Res., 51, 6304 Kato, 1994, Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Klp1) of cyclin-dependent kinase 4 activation, Cell, 79, 487, 10.1016/0092-8674(94)90257-7 Kato, 1993, Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase, CDK4, Genes Dev., 7, 331, 10.1101/gad.7.3.331 Kiyokawa, 1994, Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells, Mol. Cell. Biol., 14, 7195, 10.1128/MCB.14.11.7195 Koff, 1991, Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family, Cell, 66, 1217, 10.1016/0092-8674(91)90044-Y Lam, 1993, An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription, EMBO J., 12, 2705, 10.1002/j.1460-2075.1993.tb05932.x Lammie, 1991, D11S287, a putative oncogene on chromosome 11 q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1, Oncogene, 6, 439 LaThangue, 1994, DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control, Trends Biochem. Sci., 19, 108, 10.1016/0968-0004(94)90202-X Lee, 1994, Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation, Genes Dev., 8, 2008, 10.1101/gad.8.17.2008 Lees, 1991, The retinoblastoma protein is phosphorylated on multiple sites by human cdc2, EMBO J., 10, 4279, 10.1002/j.1460-2075.1991.tb05006.x Lees, 1993, The retinoblastoma protein binds to a family of E2F transcription factors, Mol. Cell. Biol., 13, 7813, 10.1128/MCB.13.12.7813 Lew, 1991, Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast, Cell, 66, 1197, 10.1016/0092-8674(91)90042-W Li, 1994, Transcriptional repression of the D-type cyclin-dependent kinase inhibitor pl6 by the retinoblastoma susceptibility gene product pRb, Cancer Res., 54, 6078 Mäkalä, 1994, A cyclin associated with the CDK-activating kinase M015, Nature, 371, 254, 10.1038/371254a0 Matsushime, 1991, Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle, Cell, 65, 701, 10.1016/0092-8674(91)90101-4 Morgenbesser, 1994, p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens, Nature, 371, 72, 10.1038/371072a0 Mori, 1994, Frequent somatic mutation of the MTS1/CDK4l (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma, Cancer Res., 54, 3396 Motokura, 1991, A novel cyclin encoded by a bcl1-linked candidate oncogene, Nature, 350, 512, 10.1038/350512a0 Nevins, 1992, E2F: a link between the Rb tumor suppressor protein and viral oncoproteins, Science, 258, 424, 10.1126/science.1411535 Nobori, 1994, Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 368, 753, 10.1038/368753a0 Otterson, 1994, Absence of p16lnk4 protein is restricted to the subset of lung cancer lines that retains wildtype RB, Oncogene, 9, 3375 Pardee, 1989, G1 events and regulation of cell proliferation, Science, 246, 603, 10.1126/science.2683075 Parry, 1995, Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product, EMBO J., 14, 503, 10.1002/j.1460-2075.1995.tb07026.x Polyak, 1994, p27KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell, 78, 59, 10.1016/0092-8674(94)90572-X Qin, 1994, Deregulated E2F-1 transcription factor expression leads to S-phase entry and p53-mediated apoptosis, 91, 10918 Qin, 1995, The transcription factor E2F-1 is a downstream target of RB action, Mol. Cell. Biol., 15, 742, 10.1128/MCB.15.2.742 Schmidt, 1994, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas, Cancer Res., 54, 6321 Serrano, 1993, A new regulatory motif in cell-cycle control causing specific inihibition of cyclin D/CDK4, Nature, 366, 704, 10.1038/366704a0 Serrano, 1995, Inhibition of ras-induced proliferation and cellular transformation by p16INK4, Science, 267, 249, 10.1126/science.7809631 Shan, 1994, Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis, Mol. Cell. Biol., 14, 8166, 10.1128/MCB.14.12.8166 Shay, 1991, A role for both RB and p53 in the regulation of human cellular senescence, Exp. Cell Res., 196, 33, 10.1016/0014-4827(91)90453-2 Sherr, 1993, Mammalian G1 cyclins, Cell, 73, 1059, 10.1016/0092-8674(93)90636-5 Shirodkar, 1992, The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner, Cell, 68, 157, 10.1016/0092-8674(92)90214-W Slingerland, 1994, A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells, Mol. Cell. Biol., 12, 3683, 10.1128/MCB.14.6.3683 Solomon, 1992, Role of phosphorylation in p34cdc2 activation, Mol. Biol. Cell, 3, 13, 10.1091/mbc.3.1.13 Szekely, 1992, Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses, Cell Growth Differ., 3, 149 Tam, 1994, Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4, Cancer Res., 54, 5816 Toyoshima, 1994, p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21, Cell, 78, 67, 10.1016/0092-8674(94)90573-8 Wang, 1994, The retinoblastoma tumor suppressor protein, Adv. Cancer Res., 64, 25, 10.1016/S0065-230X(08)60834-9 Weinberg, 1992, The retinoblastoma gene and gene product, Cancer Surveys, 12, 43 Weintraub, 1992, Retinoblastoma protein switches the E2F site from positive to negative element, Nature, 358, 259, 10.1038/358259a0 Welch, 1993, A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle, Cell, 75, 779, 10.1016/0092-8674(93)90497-E Welch, 1995, Disruption of retinoblastoma protein function by coexpression of its C pocket fragment, Genes Dev., 9, 31, 10.1101/gad.9.1.31 Zhou, 1994, The MTS1 gene is frequently mutated in primary human esophageal tumors, Oncogene, 9, 3737 zur Hausen, 1991, Viruses in human cancer, Science, 254, 1167, 10.1126/science.1659743